To save content items to your account,
please confirm that you agree to abide by our usage policies.
If this is the first time you use this feature, you will be asked to authorise Cambridge Core to connect with your account.
Find out more about saving content to .
To save content items to your Kindle, first ensure no-reply@cambridge.org
is added to your Approved Personal Document E-mail List under your Personal Document Settings
on the Manage Your Content and Devices page of your Amazon account. Then enter the ‘name’ part
of your Kindle email address below.
Find out more about saving to your Kindle.
Note you can select to save to either the @free.kindle.com or @kindle.com variations.
‘@free.kindle.com’ emails are free but can only be saved to your device when it is connected to wi-fi.
‘@kindle.com’ emails can be delivered even when you are not connected to wi-fi, but note that service fees apply.
Health system decision-makers need evidence on how modifiable factors contribute to inequalities to inform effective interventions. We examined ethnic group and deprivation inequalities in influenza and COVID-19 hospitalizations in England (2023–2024) among vaccine-eligible individuals, using causal mediation analysis to assess the roles of deprivation, vaccination uptake and comorbidities. For influenza, hospitalization odds were highest among Pakistani and Bangladeshi groups, compared with White British individuals. Deprivation mediated 26% of the total ethnic group effect for the Pakistani group and 41% for the Bangladeshi group, whilst comorbidities contributed little. Ethnic group differences in COVID-19 hospitalizations were minimal in this post-pandemic period. For both infections, the most deprived group had disproportionately high hospitalization compared to the least deprived. For influenza, vaccination uptake mediated 17%–26% of deprivation effects, whilst for COVID-19, there were no meaningful residual deprivation inequalities after including vaccination uptake and comorbidities. Vaccination uptake and deprivation mediate a substantial proportion of inequalities in hospitalization for influenza and COVID-19 in the vaccine-eligible cohort. Improving vaccination coverage in under-vaccinated groups should remain a public health priority.
The fields of human rights and public health intersect in important and interesting ways. Building upon advances in the Health and Human Rights movement in the late twentieth century, practitioners and educators in public health increasingly address the ways in which population health can be advanced and strengthened through an explicitly rights-based approach. Public health, which focuses primarily on community-level prevention, utilizes an interdisciplinary approach in research and teaching to ensure awareness of and respect for human rights. The Right to Health is essential for population well-being, but operationalizing this right has proven challenging and controversial. The need to take a more holistic view of health requires attention to the broader social determinants of health. Public health educators and researchers have started to utilize theoretical and methodological approaches drawn from the natural sciences, social sciences, law, and humanities to address key issues related to health and human rights in a global context.
In 2017–2018, New South Wales (NSW), Australia, experienced a hepatitis A virus (HAV) outbreak predominantly affecting men who have sex with men (MSM). We aimed to estimate immunity and identify immunity gaps among MSM in NSW. We triangulated four data sources. We tested 409 residual sera collected from males undergoing syphilis testing between August and October 2017 for anti-HAV IgG. We surveyed all publicly funded sexual health clinics about HAV testing and vaccine provision for the preceding financial year. We conducted a convenience behavioural survey of 50 men at a sex-on-premises venue in October 2017, and we analysed community survey data from 2018 to 2019 (n = 5,924). Descriptive statistics and logistic regression ere used to examine associations with immunity and vaccination. Overall serological immunity was 62.8% (257/409) and increased with age, from 50.0% in those aged under 26 years to 79.0% in those over 45 years. Clinic immunity and community survey estimates were higher (74.5% and 76.8%). Immunity gaps were identified among bisexual men, those less connected to the gay community, and people born outside Australia. NSW Health implemented targeted vaccination and community engagement in response. Multisource assessment provided actionable evidence to guide targeted vaccination and outbreak response.
William Sancho was the son of Ignatius Sancho, one of the eighteenth century's most important Black Britons. In contrast to his father, however, William's life has never been fully explored. This Element builds a new evidential trail to uncover a multifaceted career that saw the younger Sancho undertake an apprenticeship and become a bookseller, rate-paying citizen and well-connected man about town. Sancho also contributed to the early vaccination movement and the campaign against slavery. Remarkable as elements of it were, Sancho's story makes sound historical sense for someone so deeply embedded within the country's burgeoning entrepreneurial, literate, male-dominated, metropolitan and imperially-focused public sphere. Sancho was a Black man who lived a distinctly 'British' life: his importance stands on its own terms, but also alters our perspectives of what these two historical labels have traditionally implied, and the experiences that were possible as part of them.
Observational vaccine effectiveness (VE) studies provide essential real-world evidence but are prone to bias. Valid synthesis relies on rigorous risk-of-bias (RoB) assessment in systematic reviews of VE studies. Following JBI guidance, we mapped and described RoB assessment methodologies in systematic reviews of VE studies. We searched MEDLINE, Embase, and Web of Science from 1 January 2013 to 17 May 2023 and the grey literature from 1 January 2018 to 15 August 2023. Of 367 identified reviews, 38 lacked any RoB assessment, yielding 203 systematic reviews. Of these, 190 used existing tools (NOS (85/190, 44.7%), ROBINS-I (46/190, 24.2%), and JBI (11/190, 5.8%)) and 13 used an author-developed tool (13/203, 6.4%). Tools were adapted in 16.7% (34/203) of reviews and 7.2% (14/203) used multiple tools. Reviews included 20 (±25.7) observational studies, commonly cohorts (175/203, 86.2%), with COVID-19 (66/203, 32.5%) and seasonal influenza (62/203, 30.5%) frequently studied. VE was reported descriptively in 25.1% (51/203) of reviews, while 74.9% (152/203) provided meta-analyzed estimates primarily based on laboratory-confirmed infection (137/203, 67.5%) and symptomatic disease (130/203, 64.0%). Our findings indicate heterogeneous RoB assessment, reflected by use of different/multiple tools, frequent adaptations, author-developed methods, and absence of RoB assessment, highlighting the need for clearer guidance or tailored tools.
This article examines the evolution of COVID-19 vaccination efforts during 2021 and 2022 in six Central American countries, each with distinct social policy legacies and political regimes. Drawing on official data sources, the article differentiates two phases: the initial rollout of vaccines and the subsequent expansion of second-dose coverage to secure immunity. We advance three main arguments. First, differences in performance can be partly explained by the state capacities needed to implement vaccination campaigns. Second, regime type does not explain success; Nicaragua matched the performance of the most effective democratic countries. Third, presidential will accounts for the divergent trajectories of autocratic regimes. These findings underscore that in times of crisis, effective social intervention is possible without democratic pressures and accountability and highlight the need to further examine variation within nondemocratic regimes.
What are the determinants of individual uptake of vaccination? Using original data from a survey fielded in September 2021 in Germany and the United Kingdom, this study looks at the impact of three factors on individual vaccination during the COVID-19 pandemic. In a first study using observational data, we look at individual trust in institutions and political ideology. In a second study, based on experimental data, we assess the impact restrictions for unvaccinated individuals in the form of ‘green pass’ policies have on the propensity to get vaccinated.
Results from the first study show that trust in institutions and ideology are associated with vaccination uptake. Results from the survey experiment indicate that the ‘green pass’ policy scenario significantly increased willingness to get a booster shot for Germans, but not for UK respondents, due to a ceiling effect in the United Kingdom.
We further ask whether the effects of trust and policy coercion ‘amplify’ or ‘compensate’ each other. We find that trust has a ‘compensation’ effect, whereby individuals not yet vaccinated are considerably more likely to do so if they trust political institutions. Trust also compensates for other policy measures, as trusting individuals are highly likely to get vaccinated with or without the ‘green pass’ policy incentive, whereas low-trust individuals are more likely under the ‘green pass’ scenario.
Through emerging interpretations of individual “medical freedoms,” a panoply of state legislative bills seeks to undermine long-standing public health and health care requirements including recommendations to test, screen, treat, and vaccinate persons. To the extent these bills could upend decades of laws and policies protecting individual and communal health, especially among vulnerable individuals, they threaten the health — and freedoms — of all persons.
Fluctuations in disease severity occurred throughout the COVID-19 pandemic in England due to emerging variants and changing population immunity. Deaths caused by COVID-19 reduced from 2022; however, a smaller reduction was observed in deaths following a COVID-19 test. This study examines whether mortality risk within 28 days of a positive SARS-CoV-2 test remained elevated during a period of reduced disease severity. National-level routinely collected health data containing SARS-CoV-2 test results, vaccination, hospital, and death records were linked to create a population-level cohort. Individuals testing positive and negative were matched on demographic and disease characteristics. Mortality risk was compared using univariable and multivariable conditional logistic regression models for the overall time-period (March 2020–April 2022) and the focus time-period (January–April 2022). Individuals testing positive in the overall time-period had a 228% increased risk of death than those testing negative. In the focused time-period, test positive individuals had 63% higher odds of death, accounting for vaccination and previous hospitalisation. The increased risk of death associated with testing positive was greater among unvaccinated individuals (238%) than vaccinated individuals (155%). Mortality risk following COVID-19 remained elevated at the end of the pandemic, especially among unvaccinated individuals, supporting continued COVID-19 booster vaccination campaigns.
Occupational blood exposure accidents (OBEAs) pose significant risks to healthcare workers, potentially exposing them to hepatitis B (HBV), hepatitis C (HCV), and HIV. While most research focuses on hospital settings, this study assessed OBEA management in non-hospital contexts. Although our data predate the COVID pandemic, findings remain highly relevant, especially for healthcare professionals working outside hospital settings. A retrospective analysis of OBEA registry data (2006–2014) was conducted in a southern Dutch region. Data included demographics, profession, workplace, injury type, source status (HBV, HCV, HIV), risk assessment, post-exposure measures, and lab results. Chi-square and t-tests were applied. In total, 975 OBEA were reported. Among nurses, medical assistants, students, and housekeeping staff, subcutaneous needles (51–67%) and lancets (25%) were common exposure sources. Police officers mainly reported biting (26%), scratching, or spitting (70%). HBV vaccination coverage ranged from 18% (housekeeping) to over 90% (nurses, police). Post-exposure measures were taken in 52% of cases. High-risk exposures (43%) mainly affected ambulance staff, sterilization workers, police, and dentists. Sources were tested in 85% of high-risk cases: 1.4% were HBV positive, 2% HCV positive, and 1.1% HIV positive. No seroconversions occurred. Results stress the need for better HBV vaccination coverage, targeted prevention, and prompt OBEA reporting outside hospital settings.
Explores how scientific meaning and decision-making are filtered through the stories we tell about science and through our social, cultural, and personal identities. Focusing on mothers as a prominent and important identity in science communication, this Element explores both the obstacles and the opportunities for public engagement with scientific topics. After providing an overview of the nexus of science communication, stories, and identities, the author applies key insights from these topics to the case study of motherhood in the climate change and vaccination controversies. They then offer science communication strategies based on these insights for science communicators, mothers, and other caregivers. This analysis is original research that demonstrates the value of understanding stories and identities in mobilizing mothers for both science skepticism and science advocacy.
This article examines the historical transformation of childhood vaccination in the Netherlands between 1872 and 1959. It analyses how vaccination was reframed from an individual parental responsibility to a collective practice through the establishment of the ‘Rijksvaccinatieprogramma’ (National Immunisation Programme). I analyse this historical trajectory as a case of ‘public health atomism’, a strategy that achieves collective health by prioritizing individual health outcomes and local action. Rather than relying on top-down state mandates, the ‘Rijksvaccinatieprogramma’ was a consequence of co-operation between general practitioners, municipal health officials, civil society organisations, and volunteers. Drawing from published medical sources, parliamentary records, and material from local and national archives, this article provides a detailed historical account of how local governance and autonomy shaped vaccination practices, highlighting the role of the ‘entgemeenschap’ (vaccination community) as a key organisational model for situated collaboration. As such, it revisits childhood vaccination as an archetypical example of biopolitical state intervention, demonstrating how localised, flexible co-operation was instrumental in integrating vaccination into Dutch society.
This study aimed at investigating the clinical, individual, and systemic factors influencing paediatricians’ and family physicians’ clinical decision-making process in the vaccination of children during infection from the physician’s perspective.
Methods:
A qualitative study through semi-structured in-depth interviews was conducted among 10 paediatricians and 10 family physicians working in Ankara, Türkiye. The audio-recorded interviews were translated into written texts, and the obtained data was analysed using the thematic analysis method proposed by Braun and Clarke.
Results:
Four main themes were identified in of thematic analysis: (I) Impact of clinical conditions on vaccination decisions, (II) attitudes of families and their communication processes with physicians, (III) impact of practice settings and institutional factors, and (IV) vaccine postponement and compensation approaches. It was observed that the decision-making processes of the paediatricians were mainly based on the clinical evaluation criteria, while family physicians considered the expectations of the families and institutional conditions. Also, the importance of establishing effective communication with vaccine-hesitant families has been emphasized by both groups of physicians.
Conclusion:
In the immunization of infected children, decision-making is shaped in addition to medical facts in relation to the parental attitude, organizational factors within health institutions, and personal experiences of medical staff. Decisions of paediatricians are largely grounded in medical facts, whereas family practitioners assess that social and organizational factors are of higher importance. Improved adherence to medical guidelines and communication competencies of medical professionals can contribute towards medical practice consistency.
To compare and analyze COVID-19 control outcomes, including case severity, vaccination, and excess mortality, across 6 nations (USA, UK, China, Russia, Japan, and South Africa) from January 2020 to December 2022.
Methods
This study utilized data from the “Our World in Data” dataset to characterize the epidemiological features of COVID-19 across 6 countries. Generalized linear models (GLMs) were employed to examine the associations between Stringency Index (SI), vaccination coverage, and epidemiological outcomes.
Results
The USA had the highest median cases per million and the UK the highest deaths per million, while China reported the lowest for both. Hospitalization and ICU rates were highest in the UK and the USA, respectively, and lowest in Japan. Vaccination coverage was highest in China and lowest in South Africa. Excess mortality was highest in Russia and lowest in Japan. Generalized linear models indicated a negative association between the SI and cases in China (β = −40, P = 0.015), which became stronger after adjusting for vaccination (β = −311, P < 0.001), but positive associations were observed in the USA, UK, and South Africa. SI was negatively associated with excess mortality in most countries.
Conclusions
Effective pandemic control is highly context-dependent. The relationships among vaccination, variant prevalence, and health care burden were complex, shaped by implementation context, public compliance, and health care capacity.
This study aimed to evaluate the impact of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection and inactivated virus vaccination on intracytoplasmic sperm injection (ICSI) outcomes in infertile couples. A retrospective case–control study was conducted at the Royan Institute from August 2020 to March 2022. The study included 90 couples in the COVID-19 infection phase and 31 in the vaccination phase. A total of 30 infected but unvaccinated couples were compared to a control group of 60 couples with no COVID-19 infection or vaccination history. Additionally, 31 couples underwent treatment before and after receiving the Sinopharm inactivated vaccine. Key variables analysed included sperm parameters (concentration, motility, progressive motility and morphology), ovarian parameters (antral follicle count, oocyte retrieval), embryological outcomes and pregnancy outcomes. SARS-CoV-2 infection significantly reduced sperm motility (P = 0.02) and progressive motility (P = 0.01) compared to controls. Sperm concentration and morphology showed non-significant declines. Post-vaccination analysis revealed similar but statistically insignificant changes in sperm parameters. Ovarian stimulation parameters and embryological outcomes remained unaffected by both infection and vaccination. Although biochemical, clinical pregnancy and live birth rates were lower among the infected group, these differences did not reach statistical significance (p = 0.16, 0.08 and 0.09). SARS-CoV-2 infection has been associated with impaired sperm progressive motility, which may negatively influence ICSI outcomes. In contrast, vaccination with an inactivated virus does not appear to impact fertility outcomes. These findings provide crucial guidance for physicians and infertile couples managing treatments during and after the pandemic, suggesting the need for extended recovery periods before ART procedures following COVID-19 infection.
In this article, I examine the history of the concept of herd immunity, beginning with British epidemiologists in the 1920s and ending with the controversy surrounding it during the COVID-19 pandemic. I argue that competing historical and contemporary understandings of herd immunity reveal an underlying tension between observing the effects of infection-acquired herd immunity on the population dynamics of infectious diseases and actively cultivating it through immunisation. Originally offering an explanatory mechanism for the rise and fall of epidemics, the concept soon became entangled with strategies of disease control and technologies for producing immunity, particularly as mass vaccination became more common in the postwar era. This tension between observing herd immunity and cultivating it has produced diverse interpretations ranging from the temporary abatement of an outbreak due to the accumulation of infection-acquired immunity to the principle undergirding disease elimination through mass vaccination. I close by suggesting that the scientific debates and uncertainties regarding the relevance of herd immunity to public health strategies during the COVID-19 pandemic reflect this long-running tension between observing and cultivating immunity in populations.
The COVID-19 pandemic significantly impacted Saskatchewan, resulting in high per capita case counts and COVID-19-related deaths. While vaccination mandates have been a key strategy to control the pandemic, their impact in Saskatchewan remains poorly documented. This study assessed the effect of COVID-19 vaccine mandates on the incidence of COVID-19 cases and deaths in Saskatchewan during the first year following vaccine rollout.
Methods
A single-group interrupted time series analysis with multiple intervention points was conducted using aggregated daily COVID-19 incidence and mortality rates as outcome variables. The models accounted for confounding effects of daily total vaccine doses administered and public health countermeasures, including the stringency index and economic support index, from April 1, 2020 to January 20, 2022. Average daily COVID-19 incidence and mortality rates were estimated for the pre-vaccine rollout period (April 1 to December 14, 2020), and the post-rollout period (December 15, 2020 to January 20, 2022). In addition, nine supplementary initiatives were introduced during the implementation phase. All estimated effects reflected cumulative changes in trend relative to the pre-vaccination period.
Results
Cumulatively, COVID-19 incidence increased faster than the pre-vaccination trend, likely driven by successive variant surges from wild-type to Omicron, while COVID-19–related deaths remained stable across the same period. The implementation of vaccine rollout, prioritization of vaccines for high-risk populations, and proof-of-vaccination policy were effective in reducing daily COVID-19 incidence and deaths in Saskatchewan. Economic support and an increased number of daily vaccine doses administered were also associated with an improved provincial COVID-19 response. Conversely, surges in COVID-19 incidence and deaths occurred following the introduction of the centralized virtual booking system and booster doses. These surges may reflect accessibility challenges, increased testing, emergence of immune-escape variants, relaxation of public health measures before achieving herd immunity, and waning immunity over time.
Conclusions
Economic support, policy measures, and vaccination efforts played important roles in managing public health crises, hence the need for an integrated approach to managing public health crises. However, temporary surges following certain interventions underscore the need for accessible, adaptable strategies that account for variant emergence, immunity waning and public adherence.
Many countries have permitted community pharmacists to administer vaccines to increase the immunization rate. The policy of Thailand has recently expanded and permitted pharmacists to play a role in immunization.
Aim:
The objective of this study was to survey the opinion and readiness of community pharmacists as immunizers.
Methods:
This study was a prospective, mixed-methods questionnaire and semi-structured interview. The study included community pharmacists in Hatyai, Songkhla, Thailand. A Likert scale questionnaire to evaluate readiness, opinions, and barriers to providing vaccines was distributed online. The volunteer pharmacists were interviewed about their opinions, distress, and benefits of vaccination services.
Findings:
An online survey was completed by 146 pharmacists, and 12 community pharmacists agreed to be interviewed. More than 65% of respondents agreed that vaccination services in community pharmacies are easily accessible to patients. Approximately 46% of pharmacist respondents were willing to be immunizers, and 45% of respondents showed readiness with the availability of pharmacy space for handling vaccinations, their storage, and disposing of sharp objects. Almost all of the respondents showed readiness with knowledge of adverse events following immunization (AEFI) and management. However, most of the concerns were vaccine administration skills, the conflict with other professionals, and the cost of setup and management. The pharmacists required training in vaccine administration skills before providing the service.
Conclusions:
The community pharmacies were willing and ready to provide vaccination services for the National List of Essential Vaccines. Vaccine administration skills were the main barriers to vaccination. The training should be done in faculty classes or workshops.
The Secretary of the US Department of Health & Human Services, Robert Kennedy Jr is leading a political agenda against vaccination. This is undermining the delivery of life-saving vaccination programmes and provision of evidence-based information on the safety and effectiveness of vaccines for the public and health professionals. Inconsistent and conflicting messaging between health practitioners and government health agencies erodes trust in public health programmes, creating a vacuum which is often filled with mis/disinformation that presents severe consequences for families. Due to the transnational spread of diseases, we consider the implications of events in the US for routine childhood vaccination programmes in the UK. Public health agencies across the world need to be ‘Kennedy ready’; pragmatic steps must be taken to mitigate threats posed to vaccine confidence and the control of vaccine preventable diseases.
The COVID-19 pandemic, which has killed millions of people worldwide, continues to be marked by waves of reinfections. We aimed to assess the incidence and clinical characteristics of reinfection in COVID- 19 cohort.
Material and Methods
A single-center descriptive study was conducted. Data were collected from all patients who tested positive for SARS-CoV-2 via PCR from March 18, 2020, the onset of the first major COVID-19 wave, until the end of 2020. All PCR-positive patients were followed-up, and those who had SARS-CoV-2 PCR positivity again at least 90 days after the initial onset were contacted via telemedicine.
Results
5814 patients diagnosed with COVID-19 with PCR positive in the first wave were included. The incidence of reinfection among the cohort of patients infected with SARS-CoV-2 during the initial wave of COVID-19 was 0.73%. Among healthcare workers, the 1-year reinfection rate was 2.14%, 3.9 times higher than non-healthcare workers. We observed that the clinical course was milder and less complicated in patients who had reinfection. In cases of reinfection among fully vaccinated individuals, statistically significantly fewer symptoms were observed.
Conclusions
We observed that healthcare workers are at approximately four times greater risk of reinfection. Reinfections generally presented with a milder clinical course.